iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 42 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-22: Reporting owner Stevens Stacey M; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-09: Reporting owner Stevens Stacey M; Form 4; Security Employee Stock Option(right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-03: Reporting owner Stevens Stacey M; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-12-02: Reporting owner Stevens Stacey M; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-22 | Stevens Stacey M Officer (Sr.VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +100 19,501 owned after | $5.75 exercise price | 2014-12-23 | |
| 2014-12-09 | Stevens Stacey M Officer (Sr VP of Marketing & Strategy) | 4 | Employee Stock Option(right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100 19,601 owned after | $5.75 exercise price | 2014-12-11 | |
| 2014-12-03 | Stevens Stacey M Officer (Sr VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,700 17,498 owned after | $5.75 exercise price | 2014-12-03 | |
| 2014-12-02 | Stevens Stacey M Officer (Sr VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −503 19,198 owned after | $5.75 exercise price | 2014-12-03 | |
| 2014-12-01 | Stevens Stacey M Officer (Sr VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −299 19,701 owned after | $5.75 exercise price | 2014-12-03 | |
| 2014-11-03 | Stevens Stacey M Officer (Sr. VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 40,000 owned after | $2.27 exercise price | 2014-11-05 | |
| 2014-10-20 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,626 1,626 owned after | $9.09 exercise price | 2014-10-21 | |
| 2014-10-01 | Stevens Stacey M Officer (Sr. VP of Marketing & Strategy) | 4 | Employee Stock option (Right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −13,333 6,667 owned after | $2.90 exercise price | 2014-10-02 | |
| 2014-09-11 | Burns Kevin C Officer (Exec VP, COO, CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,334 8,333 owned after | $2.90 exercise price | 2014-09-15 | |
| 2014-07-21 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,098 2,098 owned after | $8.30 exercise price | 2014-07-23 | |
| 2014-07-17 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,713 0 owned after | $6.10 exercise price | 2014-07-21 | |
| 2014-07-14 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,827 0 owned after | $6.10 exercise price | 2014-07-14 | |
| 2014-06-19 | Go Jonathan Officer (Sr. VP of R&D) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.68 exercise price | 2014-06-23 | |
| 2014-06-19 | Stevens Stacey M Officer (Sr. VP of Marketing & Strategy) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $6.68 exercise price | 2014-06-23 | |
| 2014-06-19 | Burns Kevin C Officer (Executive VP, COO, CFO) | 4 | Employee Stcok Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $6.68 exercise price | 2014-06-23 | |
| 2014-06-19 | Ferry Kenneth M Officer (President, CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $6.68 exercise price | 2014-06-23 | |
| 2014-04-21 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,464 2,464 owned after | $8.58 exercise price | 2014-04-22 | |
| 2014-03-28 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $9.10 exercise price | 2014-03-31 | |
| 2014-03-28 | Goodman Robert L Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,583 3,583 owned after | $9.10 exercise price | 2014-03-31 | |
| 2014-03-27 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,787 0 owned after | $5.05 exercise price | 2014-03-28 | |
| 2014-01-21 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,422 1,422 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | Klein Michael S Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-21 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $12.75 exercise price | 2014-01-23 | |
| 2014-01-17 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $6.95 exercise price | 2014-01-21 | |
| 2014-01-17 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $5.05 exercise price | 2014-01-21 | |
| 2014-01-17 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $6.10 exercise price | 2014-01-21 | |
| 2014-01-17 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $10.15 exercise price | 2014-01-21 | |
| 2014-01-13 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,998 0 owned after | $6.95 exercise price | 2014-01-15 | |
| 2014-01-13 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,091 0 owned after | $5.05 exercise price | 2014-01-15 | |
| 2014-01-10 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $6.95 exercise price | 2014-01-13 | |
| 2014-01-10 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $5.05 exercise price | 2014-01-13 | |
| 2014-01-10 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $6.10 exercise price | 2014-01-13 | |
| 2014-01-10 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −750 0 owned after | $10.15 exercise price | 2014-01-13 | |
| 2014-01-10 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,713 0 owned after | $6.95 exercise price | 2014-01-13 | |
| 2014-01-09 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,173 0 owned after | $6.95 exercise price | 2014-01-13 | |
| 2014-01-09 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,135 0 owned after | $5.05 exercise price | 2014-01-13 | |
| 2014-01-09 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,340 0 owned after | $6.10 exercise price | 2014-01-13 |